Join        Login             Stock Quote

Mednax (MD) Downgraded To 'Hold' By Deutsche Bank, PT Cut To $73

 May 04, 2012 01:04 PM

(By Balachander) Mednax Inc. (NYSE:MD) shares were downgraded to "Hold" from "Buy" and price target lowered to $73 from $81 by Deutsche Bank analyst Darren Lehrich.

"Our U/G last Oct was predicated on growth in the core business stabilizing in the 3% to 3.5% range, and much greater potential earnings upside / multiple expansion from an accelerating M&A trend," the analyst wrote.

Lehrich acknowledges that it is still early in MD's anesthesia M&A trajectory. "Yet, we fear the co's slower pace of deals, coupled with a change in the co's margin profile due to the mix of acquired businesses, will lead to less multiple expansion than originally thought," he said.

[Related -Stock Upgrades And Downgrades: BBBY, DD, LULU, MASI, PETM, RDC, SYY]

The analyst said YTD acquisition announcements are pacing below his original expectations. "The confluence of deal pacing, a slightly lower S-U growth outlook by mgmt (to +1.5% to +3.5% or down 100 bps from prior), and mix/margin issues – lead MD's Q2 guidance to imply pretty flat yoy EPS growth. We see this outlook as a real disappointment, and indicative of potentially weaker underlying trends."

"Key downside risks: Medicaid mix, pricing, timing of M&A. Key upside risks: pot'l for Medicaid PCP code changes, M&A, buyback," the analyst said.

Sunrise, Florida-based Mednax provides neonatal, maternal-fetal, other pediatric subspecialties, and anesthesia physician services in the United States and Puerto Rico.

The stock, which has been trading in the 52-week range of $58.48 to $75.86, fell 3.7 percent to trade at $64.69 on Friday.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

article imageIs The Slump In US Manufacturing Easing?

Yesterday’s November survey data from the Philadelphia Fed hints at the possibility that a stronger trend read on...

article imageMarket Potentially Facing Near Term Technical Headwinds

After the S&P 500 Index pullback on Thursday and Friday last week, the market's advance on Monday and read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.